$15.49
0.13% yesterday
Nasdaq, Sep 27, 10:00 pm CET
ISIN
US82933R1005
Symbol
OMIC

Singular Genomics Systems Inc Stock price

$15.49
+8.36 117.25% 1M
-0.01 0.09% 6M
+1.69 12.22% YTD
+3.55 29.73% 1Y
-332.21 95.55% 3Y
-756.11 97.99% 5Y
-756.11 97.99% 10Y
Nasdaq, Closing price Fri, Sep 27 2024
-0.02 0.13%
ISIN
US82933R1005
Symbol
OMIC
Sector

Key metrics

Market capitalization $38.71m
Enterprise Value $-18.76m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.24
EV/Sales (TTM) EV/Sales -6.90
P/S ratio (TTM) P/S ratio 14.23
P/B ratio (TTM) P/B ratio 0.28
Revenue growth (TTM) Revenue growth 27.61%
Revenue (TTM) Revenue $2.72m
EBIT (operating result TTM) EBIT $-99.47m
Free Cash Flow (TTM) Free Cash Flow $-77.98m
Cash position $133.20m
EPS (TTM) EPS $-37.37
P/E forward negative
P/S forward 9.92
EV/Sales forward negative
Short interest 0.57%
Show more

Is Singular Genomics Systems Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Singular Genomics Systems Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Singular Genomics Systems Inc forecast:

1x Buy
33%
2x Hold
67%

Analyst Opinions

3 Analysts have issued a Singular Genomics Systems Inc forecast:

Buy
33%
Hold
67%

Financial data from Singular Genomics Systems Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
2.72 2.72
28% 28%
100%
- Direct Costs 11 11
17% 17%
400%
-8.15 -8.15
14% 14%
-300%
- Selling and Administrative Expenses 39 39
10% 10%
1,440%
- Research and Development Expense 45 45
7% 7%
1,659%
-92 -92
1% 1%
-3,399%
- Depreciation and Amortization 7.03 7.03
1% 1%
258%
EBIT (Operating Income) EBIT -99 -99
1% 1%
-3,657%
Net Profit -92 -92
2% 2%
-3,378%

In millions USD.

Don't miss a Thing! We will send you all news about Singular Genomics Systems Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Singular Genomics Systems Inc Stock News

Neutral
GlobeNewsWire
8 days ago
SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced today that it has received an unsolicited non-binding proposal from Concentra Biosciences, LLC (“Concentra”) to acquire all of the Company's outstanding share...
Neutral
GlobeNewsWire
15 days ago
SAN DIEGO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced today that it has received a non-binding proposal from Deerfield Management Company, L.P. and certain affiliated funds (collectively, “Deerfield”), to acquire...
Neutral
Seeking Alpha
about one month ago
Singular Genomics Systems, Inc. (NASDAQ:OMIC ) Q2 2024 Earnings Conference Call August 13, 2024 4:30 PM ET Company Participants Philip Taylor - IR Drew Spaventa - Founder, Chair and CEO Dalen Meeter - CFO Conference Call Participants Daniel Brennan - TD Cowen Matthew Sykes - Goldman Sachs Operator Greeting. Welcome to the Singular Genomics Second Quarter and Business Update Call.
More Singular Genomics Systems Inc News

Company Profile

Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. It develops two integrated solutions: G4 Instrument and PX Instrument. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company was founded by Eli Glezer and Andrew Spaventa in June 2016 and is headquartered in La Jolla, CA.

Head office United States
CEO Andrew Spaventa
Employees 265
Founded 2016
Website www.singulargenomics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today